<DOC>
	<DOCNO>NCT02869386</DOCNO>
	<brief_summary>Prehospital stroke care specialized ambulance increase thrombolysis rate , reduce alarm-to-treatment time , improve prehospital triage . Preliminary analysis suggest cost-effectiveness . However , scientific proof improve functional outcome compare usual care still lack . The objective trial show improve functional outcome deployment Stroke Emergency Mobile ( STEMO ) compare regular care .</brief_summary>
	<brief_title>Berlin PRehospital Or Usual Delivery Acute Stroke Care</brief_title>
	<detailed_description>This pragmatic , prospective , multi-center trial blind outcome assessment treatment candidate three month stroke . Treatment candidate define patient final discharge diagnosis cerebral ischemia , onset-to-alarm time ≤4 hour , symptom resolve time ambulance arrival , able walk without assistance prior emergency . These patient include emergency call predefined catchment area Berlin , Germany , cause stroke alarm dispatch center STEMO hour ( 7am-11pm , Monday-Sunday ) . About 45 % STEMO dispatch handle regular ambulance since STEMO already operation create quasi-randomized control group . B_PROUD use data B-SPATIAL registry . The B-SPATIAL registry start recruitment January 2016 . However , B_PROUD recruit patient symptom onset October 1st , 2016 later ( data access dispatch center establish first ) .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Inclusion criterion : 1 . Suspected acute stroke accord dispatcher stroke identification algorithm STEMO hour ( 7am11pm , MondaySunday ) within STEMO catchment area Inclusion criterion primary study population : 2 . Final diagnosis ischemic stroke ( ICD 10 : I63 ) TIA ( ICD 10 : G45 except G45.4 ) 3 . Confirmed onsettoalarm time ≤ 4 hour dispatch 4 . Prestroke modify Rankin scale ≤ 3 ( able ambulate , routine clinical care , patient mRS 3 usually deem suitable tissue plasminogen activator treatment ) Exclusion criterion : 1 . Symptom remission arrival emergency medical service 2 . Malignant severe primary disease life expectancy &lt; 1 year Exclusion criterion primary study population : 3 . Major surgery within 4 week study inclusion 4 . Confirmed stroke within 3 month study inclusion 5 . Absolute contraindication thrombolysis AND thrombectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>prehospital</keyword>
	<keyword>telemedicine</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>thrombectomy</keyword>
	<keyword>endovascular treatment</keyword>
	<keyword>functional outcome</keyword>
</DOC>